Tiny study tracks blood sugar in real life for type 2 diabetes
NCT ID NCT03436212
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study followed 24 adults with type 2 diabetes who use insulin pumps. Participants wore a continuous glucose monitor for 14 days at home to track blood sugar levels. The goal was to see how glucose levels relate to insulin doses and meals in everyday conditions. It was purely observational and did not test any new drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Continuous Glucose Monitor (CGM) device
What this could lead to
If successful, this could help doctors better understand how blood sugar levels change with insulin and meals in daily life, potentially improving diabetes management.
What could go wrong
This is a small, observational study with only 24 participants. It does not test a new treatment, so it cannot directly lead to a cure or new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Caen, Service Endocrinologie, Diabétologie
Caen, 14033, France